-

The Law Offices of Frank R. Cruz Announces Investigation of Olo Inc. (OLO) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Olo Inc. (“Olo” or the “Company”) (NYSE: OLO) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On February 12, 2020, Olo announced its partnership with Subway restaurants to “integrate digital orders directly into the restaurant’s point of sale for the majority of the chain’s locations” and that “[t]he partnership allows Subway’s network of more than 20,000 U.S. restaurants to more seamlessly handle digital orders from third-party marketplaces.”

On August 11, 2022, Olo released its second quarter 2022 financial results, disclosing that it is in the process of losing its business from Subway, and that it had already lost about 2,500 Subway locations during the second quarter. The Company stated that it “expect[s] Subway’s direct marketplace integration to continue with the balance of their locations being removed from our total active location counts in the fourth quarter of this year, or the first quarter of 2023.”

On this news, Olo’s stock fell $4.73, or 36.4%, to close at $8.26 per share on August 12, 2022, thereby injuring investors.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased Olo securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

Industry:

The Law Offices of Frank R. Cruz

NYSE:OLO
Release Versions
English

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

More News From The Law Offices of Frank R. Cruz

Lost Money on Dave, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 21.25% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Dave, Inc. ("Dave" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Dave, Inc. (NASDAQ: DAVE), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Dave, Inc. on November 4, 2026.If you lost money on Dave, Inc. securities, share you...

Lost Money on MNTN, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 53.62% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--MNTN, Inc. ("MNTN" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in MNTN, Inc. (NYSE: MNTN), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about MNTN, Inc. on November 4, 2026.If you lost money on MNTN, Inc. securities, share your...

Lost Money on Madrigal Pharmaceuticals, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 8.1% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Madrigal Pharmaceuticals, Inc. on Novem...
Back to Newsroom